MedCap AB MCAP

MedCap (OM:MCAP) reported revenue growth forecasts of 13.2% per year, significantly outpacing the Swedish market’s projected 3.8% annual growth. While the company has delivered average earnings growth of 25.9% per year over the past five years, its current net profit margin stands at 10%, down from 12.7% a year earlier, and earnings over the most recent year have turned negative. With expectations for strong top-line expansion and no flagged risks, investors are likely to focus on MedCap’s...